| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Vol. 145, No. 3: 211-218
Copyright © 1997 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Analysis of Current Trends in United States Mesothelioma Incidence
From Price Associates, Inc Washington, DC
Reprint requests to Dr. Bertram Price, Price Associates, Inc., 1800 K Street, N.W, Surte 718, Washington, DC 20006
Mesothelioma incidence often is interpreted as an index of past exposure to airborne asbestos. The mesothelioma rate for US males exhibits an increasing trend throughout the 1970s and early 1980s. The trend has been attributed to occupational exposure in the shipbuilding industry during World War II, in manufacturing, and in building construction. Incidence data (1973–1992) from the Surveillance, Epidemiology, and End Results Program were used to investigate current trends in age-adjusted and age-specific mesothelioma rates. An age and birth-cohort model was used to project both lifetime probabilities of mesothelioma by cohort and the annual number of cases expected over the next 70 years. The current trend in female rates is flat (age-adjusted rate = 0 30 per 100, 000) The estimated lifetime risk for females is 2.5 x 10–4, independent of birth cohort. The projected average annual number of female cases is 500. For males, the age-adjusted mesothelioma rate is increasing solely due to the age group 75 years and over, albeit at a declining growth rate Lifetime risk for males peaks at 2 x 10–3 for the 1925–1929 birth cohort, then decreases to 5 x10–4 for the 1955–1959 birth cohort. The pattern of rates reflected in the age and birth-cohort model suggests a peak in the annual number of mesothelioma cases for males at 2, 300 before the year 2000. The number of male cases then will drop during the next 50–60 years toward 500. These trends mirror the US trend in raw asbestos consumption and a reduction in workplace airborne asbestos levels. Am J Epidemiol 1997; 145: 211-18.
asbestos; incidence; mesothelioma
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. M. Krug, H. I. Pass, V. W. Rusch, H. L. Kindler, D. J. Sugarbaker, K. E. Rosenzweig, R. Flores, J. S. Friedberg, K. Pisters, M. Monberg, et al. Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma J. Clin. Oncol., June 20, 2009; 27(18): 3007 - 3013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Tsao, I. Wistuba, J. A. Roth, and H. L. Kindler Malignant Pleural Mesothelioma J. Clin. Oncol., April 20, 2009; 27(12): 2081 - 2090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Vandermeers, P. Hubert, P. Delvenne, C. Mascaux, B. Grigoriu, A. Burny, A. Scherpereel, and L. Willems Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma Clin. Cancer Res., April 15, 2009; 15(8): 2818 - 2828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Beshay, G. Carboni, B. Hoksch, M. A. Reymond, and R. A. Schmid The role of muscle flap in preventing bronchus stump insufficiency after pneumonectomy for malignant pleural mesothelioma in high-risk patients Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 621 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Christensen, J. J. Godleski, C. J. Marsit, E. A. Houseman, C. Y. Lopez-Fagundo, J. L. Longacker, R. Bueno, D. J. Sugarbaker, H. H. Nelson, and K. T. Kelsey Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma Carcinogenesis, August 1, 2008; 29(8): 1555 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Janne, G. R. Simon, C. J. Langer, R. N. Taub, A. Dowlati, P. Fidias, M. Monberg, C. Obasaju, and H. Kindler Phase II Trial of Pemetrexed and Gemcitabine in Chemotherapy-Naive Malignant Pleural Mesothelioma J. Clin. Oncol., March 20, 2008; 26(9): 1465 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Clements, G. Berry, J. Shi, S. Ware, D. Yates, and A. Johnson Projected mesothelioma incidence in men in New South Wales Occup. Environ. Med., November 1, 2007; 64(11): 747 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yan, L Welch, D Black, and P. Sugarbaker A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann. Onc., May 1, 2007; 18(5): 827 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Rice, J. J. Erasmus, C. W. Stevens, A. A. Vaporciyan, J. S. Wu, A. S. Tsao, G. L. Walsh, S. G. Swisher, W. L. Hofstetter, N. G. Ordonez, et al. Extended Surgical Staging for Potentially Resectable Malignant Pleural Mesothelioma Ann. Thorac. Surg., December 1, 2005; 80(6): 1988 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Maruyama, F. Shoji, T. Okamoto, T. Miyamoto, T. Miyake, T. Nakamura, J. Ikeda, Y. Aoki, H. Wataya, H. Asoh, et al. Triplet Chemotherapy with Cisplatin, Gemcitabine and Vinorelbine for Malignant Pleural Mesothelioma Jpn. J. Clin. Oncol., August 1, 2005; 35(8): 433 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lu, R. Perez-Soler, B. Piperdi, G. L. Walsh, S. G. Swisher, W. R. Smythe, H. J. Shin, J. Y. Ro, L. Feng, M. Truong, et al. Phase II Study of a Liposome-Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally and Pathologic Response Rates in Patients With Malignant Pleural Mesothelioma J. Clin. Oncol., May 20, 2005; 23(15): 3495 - 3501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Govindan, R. A. Kratzke, J. E. Herndon II, G. A. Niehans, R. Vollmer, D. Watson, M. R. Green, H. L. Kindler, and on behalf of the Cancer and Leukemia Group B Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B Clin. Cancer Res., March 15, 2005; 11(6): 2300 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. C. Steele and A. Klabatsa Chemotherapy options and new advances in malignant pleural mesothelioma Ann. Onc., March 1, 2005; 16(3): 345 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hazarika, R. M. White Jr., B. P. Booth, Y.-C. Wang, D. Y. Lee Ham, C. Y. Liang, A. Rahman, J. V.S. Gobburu, N. Li, R. Sridhara, et al. Pemetrexed in Malignant Pleural Mesothelioma Clin. Cancer Res., February 1, 2005; 11(3): 982 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pistolesi and J. Rusthoven Malignant Pleural Mesothelioma: Update, Current Management, and Newer Therapeutic Strategies Chest, October 1, 2004; 126(4): 1318 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Beseth, R. B. Cameron, P. Leland, L. You, F. Varricchio, R. J. Kreitman, R. A. Maki, D. M. Jablons, S. R. Husain, and R. K. Puri Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts Ann. Thorac. Surg., August 1, 2004; 78(2): 436 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Weill, J M Hughes, and A M Churg Changing trends in US mesothelioma incidence Occup. Environ. Med., May 1, 2004; 61(5): 438 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Cornia, B. A. Lipsky, G. Dhaliwal, and S. Saint Red Snapper or Crab? N. Engl. J. Med., April 1, 2004; 350(14): 1443 - 1448. [Full Text] [PDF]
|
|
|
|
|
|
D. W. Cugell and D. W. Kamp Asbestos and the Pleura: A Review Chest, March 1, 2004; 125(3): 1103 - 1117. [Full Text] [PDF]
|
|
|
|
 |
|
 P W J Bartrip History of asbestos related disease Postgrad. Med. J., February 1, 2004; 80(940): 72 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Treasure, D. Waller, S. Swift, and J. Peto Radical surgery for mesothelioma BMJ, January 31, 2004; 328(7434): 237 - 238. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Price and A. Ware Mesothelioma Trends in the United States: An Update Based on Surveillance, Epidemiology, and End Results Program Data for 1973 through 2003 Am. J. Epidemiol., January 15, 2004; 159(2): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. J. Wang, G. P. Reddy, M. B. Gotway, C. B. Higgins, D. M. Jablons, M. Ramaswamy, R. A. Hawkins, and W. R. Webb Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET RadioGraphics, January 1, 2004; 24(1): 105 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Emri Recent Developments in the Therapy of Malignant Pleural Mesothelioma Indoor and Built Environment, December 1, 2003; 12(6): 391 - 393. [Abstract] [PDF]
|
|
|
|
 |
|
 V H Gerbaudo, S Britz-Cunningham, D J Sugarbaker, and S T Treves Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma Thorax, December 1, 2003; 58(12): 1077 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Strickler, J. J. Goedert, S. S. Devesa, J. Lahey, J. F. Fraumeni Jr., and P. S. Rosenberg Trends in U.S. Pleural Mesothelioma Incidence Rates Following Simian Virus 40 Contamination of Early Poliovirus Vaccines J Natl Cancer Inst, January 1, 2003; 95(1): 38 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O Segura, A Burdorf, and C Looman Update of predictions of mortality from pleural mesothelioma in the Netherlands Occup. Environ. Med., January 1, 2003; 60(1): 50 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Lee, D. L. Everett, H.-K. G. Shu, T. M. Jahan, M. Roach III, J. L. Speight, R. B. Cameron, T. L. Phillips, A. Chan, and D. M. Jablons Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1183 - 1189. [Abstract] [Full Text]
|
|
|
|
|
|
A Baldi, A M Groeger, V Esposito, R Cassandro, G Tonini, T Battista, M P Di Marino, B Vincenzi, M Santini, A Angelini, et al. Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival Thorax, April 1, 2002; 57(4): 353 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Adams, W. Gray, R. J. O. Davies, and F. V. Gleeson Percutaneous Image-Guided Cutting Needle Biopsy of the Pleura in the Diagnosis of Malignant Mesothelioma Chest, December 1, 2001; 120(6): 1798 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Adams and F. V. Gleeson Percutaneous Image-guided Cutting-Needle Biopsy of the Pleura in the Presence of a Suspected Malignant Effusion Radiology, May 1, 2001; 219(2): 510 - 514. [Abstract] [Full Text]
|
|
|
|
|
|
J. P. C. Steele, J. Shamash, M. T. Evans, N. H. Gower, M. D. Tischkowitz, and R. M. Rudd Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma J. Clin. Oncol., December 1, 2000; 18(23): 3912 - 3917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R J. Lewis, A R. Schnatter, A. M Katz, F S Thompson, N. Murray, G. Jorgensen, and G. Thériault Updated mortality among diverse operating segments of a petroleum company Occup. Environ. Med., September 1, 2000; 57(9): 595 - 604. [Abstract] [Full Text]
|
|
|
|
|
|
A. Banaei, B. Auvert, M. Goldberg, A. Gueguen, D. Luce, and S. Goldberg Future trends in mortality of French men from mesothelioma Occup. Environ. Med., July 1, 2000; 57(7): 488 - 494. [Abstract] [Full Text]
|
|
|
|
|
|
B. JASANI;, R M RUDD, and C MULATERO Simian virus 40 and human pleural mesothelioma Thorax, August 1, 1999; 54(8): 750b - 750. [Full Text]
|
|
|
|
 |
|
 P. Schwarzenberger, D. Lei, S. M. Freeman, P. Ye, A. Weinacker, C. Theodossiou, W. Summer, and J. K. Kolls Antitumor Activity with the HSV-tk-gene-modified Cell Line PA-1-STK in Malignant Mesothelioma Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 333 - 337. [Abstract] [Full Text]
|
|